Eminase (Wulfing Pharma GmbH)
Eminase (Wulfing Pharma GmbH) Brand names, Eminase (Wulfing Pharma GmbH) Analogs
Eminase (Wulfing Pharma GmbH) Brand Names Mixture
- Synotic Otic Solution (Dimethyl sulfoxide + Fluocinolone acetonide)
Eminase (Wulfing Pharma GmbH) Chemical_Formula
C2569H3928N746O781S40
Eminase (Wulfing Pharma GmbH) RX_link
No information avaliable
Eminase (Wulfing Pharma GmbH) fda sheet
Eminase (Wulfing Pharma GmbH) msds (material safety sheet)
Eminase (Wulfing Pharma GmbH) Synthesis Reference
No information avaliable
Eminase (Wulfing Pharma GmbH) Molecular Weight
59042.3
Eminase (Wulfing Pharma GmbH) Melting Point
60 oC (Novokhatny, V.V. et al., J. Biol. Chem. 266:12994-123002 (1991))
Eminase (Wulfing Pharma GmbH) H2O Solubility
No information avaliable
Eminase (Wulfing Pharma GmbH) State
Liquid
Eminase (Wulfing Pharma GmbH) LogP
-0.516
Eminase (Wulfing Pharma GmbH) Dosage Forms
Powder for solution
Eminase (Wulfing Pharma GmbH) Indication
For lysis of acute pulmonary emboli, intracoronary emboli and management of myocardial infarction
Eminase (Wulfing Pharma GmbH) Pharmacology
Anistreplase cleaves the Arg/Val bond in plasminogen to form plasmin. Plasmin in turn degrades the fibrin matrix of the thrombus, thereby exerting its thrombolytic action. This helps eliminate blood clots or arterial blockages that cause myocardial infarction.
Eminase (Wulfing Pharma GmbH) Absorption
No information avaliable
Eminase (Wulfing Pharma GmbH) side effects and Toxicity
No information avaliable
Eminase (Wulfing Pharma GmbH) Patient Information
No information avaliable
Eminase (Wulfing Pharma GmbH) Organisms Affected
Humans and other mammals
